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Abstract
Rapid identification and antimicrobial susceptibility testing of the causative agent(s) of bloodstream infections 
may impact on the clinical outcome of patients, which is directly related to the prompt administration of an effective 
antimicrobial therapy. Empirical antimicrobial therapy is chosen on the basis of clinical and epidemiological data and 
it is administered immediately after blood sampling but, in a significant number of cases, it has to be streamlined on 
the basis of the microbiological report. Rapid identification has a clinically relevant impact on the timely selection of 
an appropriate antimicrobial therapy, especially in low-prevalence areas for antimicrobial resistance. Recently, the 
identification process of isolated bacteria has been revolutionized by the introduction of mass spectrometry (MS), 
particularly MALDI-TOF, in clinical microbiology laboratories. Furthermore, MALDI-TOF is one of the most promising 
techniques for the identification of bacterial and fungal infectious agents directly from positive blood cultures and a 
potentially useful tool for the detection of antimicrobial resistance, specifically that conferred by β-lactamases. Although 
blood culture remains, at present, the gold standard to diagnose bloodstream infections, newly developed MALDI-TOF 
methods are useful adjunctive tests to fasten the diagnostic process and further increase the diagnostic yield.
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Introduction
Bloodstream infections (BSI) are a leading cause of death 
among critically ill patients. Despite the efforts made to improve 
diagnosis and management, the incidence and number of deaths 
related to these infections are increasing, often due to inadequate 
antimicrobial therapy administered within the first 24 h [1-3]. In 
addition, empirical antimicrobial therapy may favor the selection 
and spread of antimicrobial resistant pathogens, and increase the 
frequency of invasive fungal infections [4]. Rapid identification (ID) 
and antimicrobial susceptibility testing (AST) of the causative agent(s) 
of BSI are among the most important tasks of the clinical microbiology 
laboratory since this information is essential for clinicians to select the 
most appropriate antimicrobial therapy. Recently, the identification 
process of isolated bacteria has been revolutionized by the introduction 
of mass spectrometry (MS), particularly MALDI-TOF, in clinical 
microbiology laboratories.
The aim of the present work is to review and discuss recent 
technological developments of the implementation of mass 
spectrometry to identification of bacterial and fungal infectious agents 
and possible characterization of their resistance determinants, the 
understanding of which could provide new perspectives to further 
improve and shorten the microbiological diagnosis.
Blood culture: The gold standard
Blood culture is the gold standard for the diagnosis of BSI. Blood 
cultures are widely used to discriminate whether a febrile episode is due 
to an infectious or a non-infectious cause and to provide information 
about the infectious agent, i.e., species ID and susceptibility testing to 
a panel of antimicrobials. The most relevant advances in blood culture 
technology have been made during the last decades of the 20th century 
with the introduction of automated blood culture systems, continuously 
monitoring the microbial growth. Blood culture is usually performed on 
at least two separate blood samples taken at different times, with more 
blood samples resulting in higher detection rates [5]. Blood culture 
sensitivity may vary significantly depending on the number of blood 
samples that are taken for each patient and sample volume. Within 
5 days of incubation, 99% of bloodstream infections can be detected 
using Bactec blood culture bottles [6]. Automated blood culture 
systems can detect as few as 1 colony forming unit/ml. The culture time 
for bacteria to grow to detectable levels by an automated instrument 
is approximately 12 to 24 hours of incubation for Gram-negative or 
24 to 48 hours for Gram-positive microorganisms. Longer incubation 
times and culture medium additives may be required when fastidious 
microorganisms are suspected [7]. The current method to diagnose 
BSI involves an overnight subculture from positive blood cultures 
and subsequent species ID and AST of isolated microorganisms by an 
automated system [8]. While the results of species ID and AST of the 
microorganism by the current method are reported not earlier than 48 
h after blood culture positivity, the Gram staining result is reported by 
phone to the physician rather quickly (Figure 1). The notification of 
Gram staining results in less than 1 h, influencing the timely selection 
of an appropriate antimicrobial therapy, has been associated with a 
significantly reduced mortality in patients with BSI, compared with 
delayed processing [9]. 
Variations to the standard: Direct inoculation methods
To shorten the turnaround time required for diagnosis of BSI, the 
fluid from a positive blood culture bottle may be directly inoculated into 
an automated system for ID and AST of bacteria, further referred to as 
direct methods (Figure 1). Several studies have compared the results 
of the current blood culture method with those by direct methods 
[10-18]. The direct method has been shown to yield reliable results 
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very stable and with a strong signal to noise ratio. This size range is 
dominated by ribosomal proteins, which provide accurate spectra, 
and are not markedly influenced by microbial growth conditions. 
Identification is obtained by matching the most similar spectrum in 
the database to that of the unknown microorganism. The software 
that compares the spectra generates a numerical value (score value) 
based on the similarities between the observed and stored data 
sets. In general, a score value above 2.0 is considered a valid species 
identification, whereas values between 2.0 and 1.7 represent reliable 
genus identification, though it has been proposed that cut-off values 
could be lowered down to 1.4 without compromising the accuracy of 
results [21-25].
Rapid MALDI-TOF MS identification of bacteria causing 
bloodstream infections 
MALDI-TOF MS can identify bacteria within a few minutes and 
only a small amount of microbial biomass is required for analysis. 
For these reasons, MALDI-TOF MS is one of the most promising 
techniques for the identification of infectious agents directly from 
positive blood culture [23,26-30].
Better performances have been described for Gram-negative than 
for Gram-positive bacteria [22,25,31,32]. Differences in the sample 
processing methods may account, at least in part, for the observed 
variability in correct identification rates [33]. In order to minimize 
possible interferences by other proteins, several sample preparation 
protocols have been developed that separate bacterial and host cells 
and proteins through cell lysis and/or differential centrifugation steps 
[34-36]. These protocols usually yield bacterial samples largely devoid 
of blood components but may be laborious and not very effective in 
recovering microorganisms from BC containing low bacterial loads. In 
fact, it has been shown by spike/dilution experiments that the number 
of bacteria in BC may be a critical factor for successful identification by 
MALDI-TOF [36]. Moreover, due to the additional processing time, 
most microbiological laboratories use these methods in batches for 
organizational reasons, thus reducing the gain in time obtained by a 
faster method. In addition, the significant hands on time of the various 
sample preparation protocols described in the literature may hinder 
their implementation in laboratories with limited human resources. As 
an alternative to differential centrifugations, bacteria can be separated 
from BC using serum separator tubes (SST), which is rapid and allows 
to purify bacteria with reasonably good yields. Sporadically, removal 
of blood cells by SST centrifugation may be not very efficient and, 
therefore, a few samples should be processed a second time. 
The final step in sample preparation for MALDI-TOF analysis 
is lysis of bacteria and extraction of intracellular proteins. This may 
be effectively achieved by a standard ethanol/formic acid protein 
extraction protocol, followed by centrifugation to remove intact 
bacteria and bacterial cell debris [34-36]. Alternatively, bacterial lysis 
and extraction of bacterial proteins may be carried out directly on the 
steel target plate before addition of matrix solution [25,37]. To this 
regard, a method which is rapid, reliable, simple, and easy to integrate 
into the diagnostic routine has been proposed recently by Barnini et al. 
[25] in order to be fully applicable to diagnostic routine, without the 
need to work in batches.
Assessment of β-lactamase mediated resistance by MALDI-
TOF
MALDI-TOF MS is a potentially useful tool for the detection 
of antimicrobial resistance, particularly that conferred by β 
-lactamases [38-41]. Resistance to β-lactam antibiotics can be tested 
for Gram-negative rods (being better for Enterobacteriaceae than for 
Pseudomonas aeruginosa) and, recently, also for Gram-positive cocci 
[14,15,17,18]. Treatment with detergents, such as saponin, before 
inoculation into the appropriate ID and AST cards improves the 
recovery of Gram-positive cocci as well as P. aeruginosa from positive 
blood culture, probably by releasing intracellular bacteria from human 
blood cells [18]. Although some isolates may be missed or misidentified 
by the direct method, a good categorical agreement between the 
direct and standard methods is usually observed for AST results, with 
relatively low overall error rates for the direct method [13,14,17,18]. 
The main sources of errors by direct methods are mixed cultures and a 
too small inoculum size. As a small (6-10%), but significant, percentage 
of specimens appearing monomicrobial at the Gram staining results 
to be polymicrobial after subculture [11,13,14,19] the results obtained 
with the direct method should be considered preliminary until the 
inoculum has been confirmed to be monomicrobial by subculture. This 
does not delay the report of results as the mono/polymicrobial nature of 
specimens can be assessed on subcultures inoculated the previous day. 
As an alternative to the direct methods, the AST can be accomplished 
after a short-term subculture (<6 h) in solid medium [20] with more 
reliable results for Gram-negative (97.6%) than for Gram-positive 
(64%) bacteria [20]. 
Rapid methods for AST represent an important advancement in 
the diagnosis of BSI as the results are available 12-24 h earlier than 
with the current method, depending on the chosen method and on 
how the workflow is organized, thus allowing a rapid selection of the 
appropriate antimicrobial therapy.
MALDI-TOF MS identification of bacteria causing 
bloodstream infections 
Mass spectrometry (MS) is a highly accurate analytical technique 
that allows measuring the mass/charge ratio of a variety of compounds. 
Matrix-assisted laser desorption/ionization time of flight (MALDI-
TOF) is the most widely used MS technique for the analysis of 
biomolecules, particularly for polypeptides. In recent years, MALDI-
TOF MS has become an effective instrument for identification of 
bacteria from isolated colonies. For microbial identification, the 
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Figure 1: Schematic representation of the various steps of the different 
diagnostic procedures described in the text.
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inoculum. This result clearly indicates that conventional testing from 
subcultured isolates is still necessary for validation of the results [53].
More recently, an innovative MALDI-TOF MS-based approach 
to identify a specific signature of bloodstream infections caused 
by Candida albicans was described by Sendid et al. [54]. A similar 
approach was previously used in the set up with tests aimed at detecting 
Candida cell wall moieties (e.g., mannans, glucans) by immunocapture 
or biochemical techniques in sera of patients with candidaemia [55]. 
These tests are particularly interesting, as one of the major issues in 
the management of systemic infections is the difficulty of an early 
diagnosis, which is required for a favourable outcome. Following 
optimization of pre-analytical procedures, Sendid et al. [54] aimed 
at extracting oligosaccharides from serum and were able to identify a 
specific peak of m/z 365 by mass spectrum analysis, which was identified 
as a disaccharide. Interestingly, this disaccharide was specifically 
associated to sera obtained from patients with candidaemia and it was 
absent in control sera collected from healthy subjects. Mouse models 
of Candida albicans colonization and infection showed that this signal 
was specifically associated with tissue invasion, suggesting that clinical 
evaluation of its usefulness in discriminating colonized and infected 
patients would be feasible. Such a study highlights the potentiality of 
this mass spectrometry-based method to rapidly discriminate between 
colonized individuals and patients with disseminated candidiasis based 
on the presence of this biomarker [54].
Combining PCR with MS for rapid diagnosis of BSI
Another promising application of mass spectrometry to the 
identification of microorganisms causing bloodstream infections is 
ElectroSpray Ionization Mass Spectrometry (ESI-MS) used on the 
amplicons generated by broad-spectrum PCR to potentially identify 
any microorganism present in a clinical specimen [56]. Using mass 
spectrometry, the mass of each PCR amplicon is determined and the 
nucleotide base composition is calculated and compared to a database, 
achieving the identification of the pathogen. Microbial identification in 
positive blood culture aliquots by PCR/ESI-MS showed 96.8% sensitivity 
and 98.5% specificity in comparison with the current method [57]. 
When PCR/ESI-MS was performed in whole blood specimens, thus 
avoiding culture, sensitivity and specificity for the molecular method 
were 50% and 93.8%, respectively. The accuracy of the PCR/ESI-MS 
method may be comparable to that of a real-time PCR-based system 
[57], though the two methods may have advantages and drawbacks. 
Real-time PCR is very rapid and relatively simple to perform but the 
number of detectable microbial species is limited to predefined panels 
of 25-60 species. The PCR/ESI-MS method can identify more than 400 
species of bacteria with a reasonable turnaround time (6-8 h) and has a 
high-throughput capacity but it is more technically complex than real-
time PCR, and it may be more difficult to integrate into the standard 
laboratory workflow.
Specific PCR-based assays, such as the Xpert MRSA/SA assay, have 
been developed and evaluated for their ability to identify in 1 h S. aureus 
and methicillin-resistance from blood cultures with Gram-positive cocci in 
clusters and tetrads [58,59]. The Xpert MRSA/SA BC (Cepheid, Sunnyvale, 
CA) is a real-time PCR-based method that detects sequences within the 
staphylococcal protein A (spa) gene, the gene for methicillin resistance 
(mecA), and the staphylococcal cassette chromosome (SCCmec) inserted 
into the S. aureus chromosomal attB insertion site. Inclusion of the attB 
insertion site and the mecA gene targets enables the assay to discriminate 
methicillin-resistant S. aureus from methicillin-resistant coagulase-
negative Staphylococcus species that may occur in molecular tests that 
target only the SCCmec cassette. In a recent report, Romero-Gómez et al. 
by MS as hydrolysis of the β-lactam ring by β-lactamases results 
in the disappearance of the original mass peak of the antibiotic and 
appearance of the corresponding products generated by hydrolysis 
[42]. On the contrary, mechanisms of resistance other than those 
mediated by β-lactamases, such as mutated porins and up-regulation 
of efflux pumps, cannot be detected by MALDI-TOF, at present.
A few studies have been performed to discriminate methicillin-
resistant (MRSA) from susceptible (MSSA) Staphylococcus aureus 
strains using MALDI-TOF MS. Considerable diversity between MALDI-
TOF fingerprints from different MRSA strains has been demonstrated, 
suggesting the general feasibility of MALDI-TOF-based discrimination 
of MRSA lineages. Of course, further independent clonal complexes 
should be analyzed and incorporated into the typing scheme to become 
a rapid first-line screening tool for prediction of clonal lineages and 
outbreak investigation. Employing routine real-time typing has the 
potential to improve MRSA surveillance [43]. Discordant results are 
often due to systematic database-related taxonomical differences that 
can be reduced in the future with an expanding database. 
Another, recently described application of MALDI-TOF MS for 
the detection of antimicrobial resistance is based on the identification 
of blaKPC carbapenemase gene-bearing plasmids conferring 
carbapenem resistance. Rapid methods for tracking plasmids carrying 
carbapenemase genes could greatly benefit infection control efforts 
[44]. Plasmid identification by MALDI-TOF MS can be accomplished 
in 10 min from isolated colonies and 30 min from positive blood 
cultures, thus showing the potential clinical utility of this method.
All together, MALDI-TOF MS allows rapid identification of 
bacteria [45,46] and potentially provides important information about 
β-lactamase-mediated resistance, which may support the early start of 
an appropriate antimicrobial therapy.
Rapid MALDI-TOF MS identification of fungi causing 
bloodstream infections 
Fungal systemic infections are on the rise and their increasing 
incidence has been linked to recent advanced treatment strategies for 
long degenerative pathologies, which have led to a higher number 
of immunocompromised patients [47]. Systemic infections due to 
Candida spp. are characterized by a high mortality rate, especially 
when associated to septic shock, with percentages rising to up to 97.6% 
if patients are not treated with adequate antifungal therapy within 24 
hours [48]. Th e possibility of a rapid identification of fungal species 
directly from blood samples would significantly speed up routine 
workflow and a reduction in turnaround time, ultimately benefitting 
the patient. To this end, MALDI-TOF MS has been proven to provide 
an early diagnosis of yeast species directly from blood cultures, even 
though the different protocols used may yield variable outcomes 
[22,48-52]. A recent paper by Idelevich et al. investigated the usefulness 
of a combined approach in which MALDI-TOF MS identification is 
applied to very short-term blood cultures [53]. The same biomass from 
very short-term blood cultures is also used for an early inoculation 
of an automated susceptibility testing device [53]. The ability of mass 
spectrometry to identify different yeast species was confirmed when 
this technique was directly applied to early positive blood cultures, 
even though the success rate was strongly associated with the fungal 
concentration in the sample, as also reported by others [51]. However, 
when yeast cell pellets prepared with the same standard kit protocol 
were used for antifungal susceptibility testing with the main aim to 
provide an early response on drug susceptibility, performance was sub 
optimal [53]. In fact, for some of the isolates the test aborted, most 
likely because of the limited number of fungal cells in the starting 
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Optimal testing parameters for blood cultures. Clin Infect Dis 38: 1724-1730.
7. Kirn TJ, Weinstein MP (2013) Update on blood cultures: how to obtain, process, 
report, and interpret. Clin Microbiol Infect 19: 513-520. 
8. Jordan JA, Durso MB (2005) Real-time polymerase chain reaction for detecting 
bacterial DNA directly from blood of neonates being evaluated for sepsis. J Mol 
Diagn; 7: 575-581.
9. Barenfanger J, Graham DR, Kolluri L, Sangwan G, Lawhorn J, et al. (2008) 
Decreased mortality associated with prompt Gram staining of blood cultures. 
Am J Clin Pathol 130: 870-876.
10. Bruins MJ, Bloenberger P, Ruijs GJ, Wolfhagen MJ (2004) Identification and 
susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by 
direct inoculation from positive Bactec blood culture bottles into Vitek 2. J Clin 
Microbiol 42: 7-11.
11. de Cueto M, Ceballos E, Martinez-Martinez L, Perea EJ, Pascual A (2004) Use 
of positive blood cultures for direct identification and susceptibility testing with 
the Vitek 2 system. J Clin Microbiol 42: 3734-3738.
12. Funke G, Funke-Kissling P (2004) Use of the BD Phoenix automated 
microbiology system for direct identification and susceptibility testing of Gram-
negative rods from positive blood cultures in a three-phase trial. J Clin Microbiol 
42: 1466-1470.
13. Lupetti A, Barnini S, Castagna B, Capria AL, Nibbering PH (2010) Rapid 
identification and antimicrobial susceptibility profiling of Gram-positive cocci in 
blood cultures with the Vitek 2 system. Eur J Clin Microbiol Infect Dis 29: 89-95.
14. Lupetti A, Barnini S, Castagna B, Nibbering PH, Campa M (2010) Rapid 
identification and antimicrobial susceptibility testing of Gram-positive cocci in 
blood cultures by direct inoculation into the BD Phoenix system. Clin Microbiol 
Infect 16: 986-991.
15. Gherardi G, Angeletti S, Panitti M, Pompilio A, Di Bonaventura G, et al. (2012) 
Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid 
identification and antibiotic susceptibility testing directly from blood cultures of 
Gram-negative and Gram-positive isolates. Diagn Microbiol Infect Dis 72: 20-31.
16. Yonetani S, Okazaki M, Araki, K, Makino H, Fukugawa Y, et al. (2012) Direct 
inoculation method using BacT/Alert 3D and BD Phoenix system allows rapid 
and accurate identification and susceptibility testing for both Gram-positive 
cocci and Gram-negative rods in aerobic blood cultures. Diagn Microbiol Infect 
Dis 73:  129-134.
17. Beuving J, van der Donk CF, Linssen CF, Wolffs PF, Verbon A (2011) 
Evaluation of direct inoculation of the BD Phoenix system from positive Bactec 
blood cultures for both Gram-positive cocci and Gram-negative rods. BMC 
Microbiol 11: 156.
18. Lupetti A, Barnini S, Morici P, Ghelardi E, Nibbering PH, et al. (2013) Saponin 
promotes rapid identification and antimicrobial susceptibility profiling of Gram-
positive and Gram-negative bacteria in blood cultures with the Vitek 2 system. 
Eur J Clin Microbiol Infect Dis 32: 493-502.
19. Waites KB, Brookings ES, Moser SA, Zimmer BL (1998) Direct bacterial 
identification from positive BacT/Alert blood cultures using MicroScan overnight 
and rapid panels. Diagn Microbiol Infect Dis 32: 21-26.
20. Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G, et al. (2014) 
Rapid identification of microorganisms from positive blood cultures by MALDI-
TOF mass spectrometry subsequent to very short-term incubation on solid 
medium. Clin Microbiol Infect 20: 1001-1006.
21. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, et al. (2009) Ongoing 
revolution in bacteriology: routine identification of bacteria by matrix-assisted 
laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49: 
543-551.
22. Buchan BW, Riebe KM, Ledeboer NA (2012) Comparison of the MALDI Biotyper 
system using Sepsityper specimen processing to routine microbiological 
methods for identification of bacteria from positive blood culture bottles. J Clin 
Microbiol 50: 346-352.
23. Lagacé-Wiens PR, Adam HJ, Karlowsky JA, Nichol KA, Pang PF, et al. (2012) 
Identification of blood culture isolates directly from positive blood cultures 
by use of matrix-assisted laser desorption ionization-time of flight mass 
spectrometry and a commercial extraction system: analysis of performance, 
cost, and turnaround time. J Clin Microbiol 50: 3324-3328.
[59] described that the sensitivity and specificity of the Xpert MRSA/SA 
BC assay were 96.0% and 100%, respectively. The accuracy of the method 
combining the MALDI-TOF and Xpert MRSA/SA BC systems was 
98.9%, with a negative and positive predictive value of 98.5% and 100%, 
respectively [59]. However, one limitation of the Xpert is the presence of 
mutations or polymorphisms in primer and probe binding regions, which 
may affect detection of new or unknown MRSA variants, resulting in a 
false-negative result. The PCR/MS technologies could fasten and increase 
the detection of microbial pathogens in BSI but, at present, they cannot 
replace conventional microbiological methods for the assessment of 
antimicrobial susceptibility of the etiologic agent, and still require 
further substantial investigation before their inclusion in routine use 
as adjunctive tests.
Conclusions
An ideal method for the diagnosis of BSI should rapidly identify 
the infectious agent(s) and its antimicrobial susceptibility profile in 
order to timely select an effective antimicrobial therapy. At present, 
an empirical antimicrobial therapy is chosen on the basis of clinical 
and epidemiological data and it is administered immediately after 
blood sampling. Rapid ID has a clinically relevant impact to streamline 
the appropriate antimicrobial therapy. To this regard, at present 
the MALDI-TOF based direct method represents the best option 
for microbial ID, as it is rapid, reliable, and relatively inexpensive. 
Moreover, since the impact of rapid ID on antimicrobial selection varies 
significantly between low- and high-prevalence areas for antibiotic 
resistance [29], we believe that a rapid method for AST should also 
be performed. To this aim, at present, the previously described direct 
inoculation methods are a valid option to provide accurate results 12-
24 h earlier than the current method. The recently described results 
for the detection of bacterial β-lactamase resistance by MALDI-TOF 
are interesting and promising, although further research is required to 
establish effective methodologies allowing wider detection of resistance 
determinants by mass spectrometry.
Another important issue regards the additional processing time 
required by some of these new methods, which may hinder their 
implementation in clinical microbiology laboratories. Additional 
studies focused on simplification of diagnostic procedures will 
facilitate the complete integration of newly developed methods into 
the diagnostic routine. 
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